#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial — Core IM | Internal Medicine Podcast

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?

Sponsors: Post Investment: Real Estate Syndications || Hellofresh

Show Notes & Transcript

02:08 Framework for thinking about obesity
03:42 History of obesity treatment
06:29 Gila monsters and GLP and GIP mechanisms
08:29 Story of how medications for diabetes were found to have a weight loss benefit
12:50 SURMOUNT-1 trial

Tags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistant

Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Our Sponsors:
* Check out ElevenReader and use my code PODCAST for a great deal: https://elevenreader.io

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy